Bioventus (BVS) Inventory Average (2021 - 2026)

Bioventus has reported Inventory Average for 6 years, with the latest figure at $82.7 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory Average fell 11.31% year-over-year to $82.7 million; the trailing twelve-month figure through Mar 2026 stood at $82.7 million (down 11.31% YoY), and the FY2025 full-year result was $87.4 million, down 4.95% from the prior year.
• Inventory Average for Q1 2026 stood at $82.7 million, down from $89.3 million in the prior quarter.
• The five-year high for Inventory Average was $96.9 million in Q3 2023, with the low at $63.2 million in Q2 2022.
• Historically, Inventory Average has averaged $86.9 million across 5 years, with a median of $91.3 million in 2024.
• Annual changes were most pronounced in 2022 — Inventory Average soared 106.89% — and 2026, when it declined 11.31%.
• Bioventus' Inventory Average stood at $80.9 million in 2022, then advanced by 16.81% to $94.4 million in 2023, then dropped by 3.38% to $91.3 million in 2024, then retreated by 2.19% to $89.3 million in 2025, then slipped by 7.33% to $82.7 million in 2026.
• The last three Inventory Average figures came in at $82.7 million (Q1 2026), $89.3 million (Q4 2025), and $96.4 million (Q3 2025), per Business Quant data.